STX insider trades under 10b5-1: option exercises and a 1,724-share sale
Rhea-AI Filing Summary
Teh Ban Seng, EVP & Chief Commercial Officer of Seagate Technology Holdings plc (STX), reported transactions on 08/11/2025 executed under a Rule 10b5-1 trading plan adopted on 10/31/2024. On that date he acquired 532 shares at $68.83, 313 shares at $87.34 and 879 shares at $64.31 (total 1,724 shares acquired via option-related transactions) and sold 1,724 shares at $151.61.
The Form 4 shows direct beneficial ownership levels reported after each transaction: 6,679, 6,992, 7,871 and, after the sale, 6,147 ordinary shares. The filing also lists non-qualified (NQ) options associated with the exercised grants, with exercisable/expiration dates including 09/09/2029, 09/09/2028 and 09/11/2030, and explains the options are subject to four-year vesting schedules. All activity is reported as direct ownership and was effected pursuant to the disclosed 10b5-1 plan.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine, pre-planned option exercises and an equivalent share sale under a 10b5-1 plan; neutral to investor outlook.
The reporting person executed option-related acquisitions totaling 1,724 ordinary shares and contemporaneously sold 1,724 shares on 08/11/2025, all pursuant to a Rule 10b5-1 plan adopted on 10/31/2024. The filing lists exercise prices of $68.83, $87.34 and $64.31, and a sale price of $151.61. Resulting direct beneficial ownership after the transactions is reported as 6,147 shares. Because the trades were pre-arranged under a 10b5-1 plan and involve option exercises, the action appears administrative rather than a signal of new company-specific information.
TL;DR: Transactions comply with a disclosed 10b5-1 plan and include standard vesting language; governance disclosure is complete.
The Form 4 identifies the plan adoption date and provides vesting details for the option grants, noting four-year schedules and specific vesting commencement dates. The filing includes exercisable and expiration dates for the NQ options (09/09/2029, 09/09/2028, 09/11/2030) and signatures consistent with required attestations. From a governance perspective, the disclosure is specific about the plan and vesting terms and therefore meets typical Section 16 transparency expectations.